200 related articles for article (PubMed ID: 34591171)
1. Multicenter, cross-sectional, observational study on Epstein-Barr viral infection status and thiopurine use by age group in patients with inflammatory bowel disease in Japan (EBISU study).
Miura M; Shimizu H; Saito D; Miyoshi J; Matsuura M; Kudo T; Hirayama D; Yoshida M; Arai K; Iwama I; Nakase H; Shimizu T; Hisamatsu T
J Gastroenterol; 2021 Dec; 56(12):1080-1091. PubMed ID: 34591171
[TBL] [Abstract][Full Text] [Related]
2. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
Nystad TW; Myrmel H
J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Abbott Architect, Siemens Immulite, bioMerieux Vidas, and Euroimmune assays for determination of Epstein-Barr virus serological diagnosis.
Appak O; Ozkaratas MH; Sayiner AA
J Med Virol; 2021 Nov; 93(11):6309-6316. PubMed ID: 34375007
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.
Corrales I; Giménez E; Navarro D
Clin Vaccine Immunol; 2014 May; 21(5):684-8. PubMed ID: 24623623
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of primary Epstein-Barr virus infection disease spectrum and its reactivation in children, in Suzhou, China.
Shi T; Huang L; Chen Z; Tian J
J Med Virol; 2021 Aug; 93(8):5048-5057. PubMed ID: 33719067
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of immunoblot-based assay for detecting Epstein-Barr virus viral capsid antibodies].
Altuğlu I; Aksoy A; Zeytinoğlu A; Orman M
Mikrobiyol Bul; 2010 Apr; 44(2):231-6. PubMed ID: 20549957
[TBL] [Abstract][Full Text] [Related]
8. [Atypical profile problem in serological diagnosis of EBV].
Varıcı Balcı FK; Özbek ÖA; Sayıner AA
Mikrobiyol Bul; 2017 Oct; 51(4):378-386. PubMed ID: 29153068
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan.
Shinkura R; Yamamoto N; Koriyama C; Shinmura Y; Eizuru Y; Tokunaga M
J Med Virol; 2000 Apr; 60(4):411-6. PubMed ID: 10686024
[TBL] [Abstract][Full Text] [Related]
11. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
[TBL] [Abstract][Full Text] [Related]
12. Impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease.
de Francisco R; Castaño-García A; Martínez-González S; Pérez-Martínez I; González-Huerta AJ; Morais LR; Fernández-García MS; Jiménez S; Díaz-Coto S; Flórez-Díez P; Suárez A; Riestra S
Aliment Pharmacol Ther; 2018 Oct; 48(7):723-730. PubMed ID: 30095176
[TBL] [Abstract][Full Text] [Related]
13. SERO-PREVALENCE OF EPSTEIN-BARR VIRUS IN IRAQI INFLAMMATORY BOWEL DISEASE.
Ghazi HF; Alubaidi GT; Fahad HM
Wiad Lek; 2022; 75(8 pt 2):1979-1984. PubMed ID: 36129082
[TBL] [Abstract][Full Text] [Related]
14. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
Chougule D; Nadkar M; Rajadhyaksha A; Pandit-Shende P; Surve P; Dawkar N; Khadilkar P; Patwardhan M; Kaveri S; Ghosh K; Pradhan V
J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074
[TBL] [Abstract][Full Text] [Related]
15. EBV Status and Thiopurine Use in Pediatric IBD.
Gordon J; Ramaswami A; Beuttler M; Jossen J; Pittman N; Lai J; Dunkin D; Benkov K; Dubinsky M
J Pediatr Gastroenterol Nutr; 2016 May; 62(5):711-4. PubMed ID: 26655944
[TBL] [Abstract][Full Text] [Related]
16. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A
J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
[TBL] [Abstract][Full Text] [Related]
17. The impact of serological features in Chinese children with primary or past Epstein-Barr virus infections.
Huang Y; Wei C; Zheng K; Zhao D
Virol J; 2013 Feb; 10():55. PubMed ID: 23406068
[TBL] [Abstract][Full Text] [Related]
18. EBV VCA IgM and cytomegalovirus IgM dual positivity is a false positive finding related to age and hepatic involvement of primary Epstein-Barr virus infection in children.
Sohn MJ; Cho JM; Moon JS; Ko JS; Yang HR
Medicine (Baltimore); 2018 Sep; 97(38):e12380. PubMed ID: 30235701
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
[TBL] [Abstract][Full Text] [Related]
20. The serological signs of the Epstein-Barr virus (EBV) activity in the elderly.
Ternák G; Szúcs G; Uj M
Acta Microbiol Immunol Hung; 1997; 44(2):133-40. PubMed ID: 9330661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
